GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Inspira Technologies Oxy
Inspira Technologies is developing a system for blood oxygenation without intubation. Its stock price is a venture bet on its innovative medical technology. The chart reflects high volatility and dependence on news about clinical trials and FDA approvals.
Share prices of companies in the market segment - Therapeutic medical equipment
Inspira Technologies is an Israeli medical company that has developed an innovative system for blood oxygenation without the need for intubation. We have classified it as "Therapeutic Medical Equipment." The chart below shows how the market values breakthrough technologies in intensive care.
Broad Market Index - GURU.Markets
Inspira Technologies is developing the ART blood oxygenation system, which aims to be a less invasive alternative to ECMO machines. Its innovative nature earns it a spot in the GURU.Markets index. The chart below compares its performance with the overall market.
Change in the price of a company, segment, and market as a whole per day
IINN - Daily change in the company's share price Inspira Technologies Oxy
Inspira Technologies Oxy B.H.N.'s daily stock price fluctuates reflecting volatility in the medical device sector. The index is sensitive to news about the development and approval of its blood oxygenation system.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
Inspira Technologies Oxy B.H.N. Ltd. is a company in the medical device sector. This chart illustrates the high volatility of the MedTech industry. Comparing it to IINN, which focuses on blood oxygenation systems, helps assess the extent to which its innovative products contribute to its volatility.
Daily change in the price of a broad market stock, index - GURU.Markets
Inspira Technologies develops devices for blood oxygenation without the need for intubation. Shares of this innovative medical technology company are responding to clinical successes and regulatory decisions, contributing to the overall volatility of the healthcare sector.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Inspira Technologies Oxy
Inspira Technologies's growth is the story of its unique system for blood oxygenation without intubation. Its 12-month market cap depends entirely on progress toward FDA approval. Success in its ART technology could offer a new, less invasive alternative for patients with acute respiratory failure.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
Inspira Technologies is an early-stage medical device company developing an innovative blood oxygenation system. Its stock price is entirely speculative and based on investor confidence in its futuristic technology, not on current financial performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Inspira, which develops innovative medical equipment, is a speculative bet on the future of medicine. Its stock price is not tied to the economy, but rather driven by its technological breakthroughs and partnerships. The chart tells the story of investors' faith that its innovation will become the new standard.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Inspira Technologies Oxy
Inspira Technologies develops blood oxygenation systems. Being in the development and approval phase, its monthly pricing is dependent on news. Progress in clinical trials and interactions with the FDA are the main events shaping expectations.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Inspira Technologies is developing a medical device for blood oxygenation without intubation. This is a potentially breakthrough technology for critical care. The dynamics of the medical equipment sector reflect the demand for innovation. Inspira's story is a risky bet that its technology will prove effective and safe, and will change the standard of care.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Inspira Technologies OXY B.H.N. Ltd. is developing an innovative system for blood oxygenation without the need for intubation. Its business is betting on a breakthrough in critical care medicine. The broader market chart serves as a backdrop to see how its potentially revolutionary technology, currently in development, impacts its speculative stock.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Inspira Technologies Oxy
Inspira Technologies develops innovative medical equipment for respiratory support. Weekly stock performance is highly volatile and depends on key events, including news of FDA approval, clinical trial results, and potential hospital demand.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Inspira Technologies develops innovative medical equipment for respiratory support. Weekly stock performance is highly volatile and depends on key events, including news of FDA approval, clinical trial results, and potential hospital demand.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Shares of Inspira, a medical technology company, live in a world of their own. Their performance is driven by news of regulatory approvals. A chart comparing the stock to the S&P 500 clearly demonstrates how the stock can rise or fall, completely ignoring the broader market.
Market capitalization of the company, segment and market as a whole
IINN - Market capitalization of the company Inspira Technologies Oxy
Inspira Technologies' market capitalization tells the story of an Israeli company developing a new technology for intubation-free blood oxygenation. The company's stock price reflects investors' faith in the potential of this less invasive approach. Its volatility reflects development news and trial data.
IINN - Share of the company's market capitalization Inspira Technologies Oxy within the market segment - Therapeutic medical equipment
Inspira Technologies is developing a blood oxygenation system that could become an alternative to invasive mechanical ventilation. Its market capitalization reflects the potential of its breakthrough technology. The chart below shows the volatility of its valuation as the company moves toward regulatory approvals.
Market capitalization of the market segment - Therapeutic medical equipment
Inspira Technologies is developing a system for blood oxygenation without the need for intubation, which could become an alternative to mechanical ventilation. The chart below shows the overall market capitalization of the therapeutic medical equipment sector. It reflects the potential of breakthrough technologies to solve critical medical problems.
Market capitalization of all companies included in a broad market index - GURU.Markets
Shown here is a new life-saving technology. Inspira Technologies is developing a device for oxygenating blood without invasive ventilation. The line on the graph is a bet that this technology will become the new standard in intensive care units.
Book value capitalization of the company, segment and market as a whole
IINN - Book value capitalization of the company Inspira Technologies Oxy
Inspira Technologies' foundation is its intellectual property (IP) for the ART device, designed to enrich blood with oxygen without invasive ventilation. This represents cutting-edge medical capital. The chart below shows how the Israeli company accumulates and expends resources to develop and obtain approval for its innovative technology.
IINN - Share of the company's book capitalization Inspira Technologies Oxy within the market segment - Therapeutic medical equipment
Inspira Technologies develops a medical device for blood oxygenation without intubation. Its assets include R&D centers and production lines. The chart shows the company's share of this innovative medical infrastructure.
Market segment balance sheet capitalization - Therapeutic medical equipment
Medical equipment development, as the BCap_Ges chart shows, is capital-intensive. Inspira Technologies, when creating its oxygenation systems, must invest in R&D and precision manufacturing. The chart confirms the high barriers to entry in this industry.
Book value of all companies included in the broad market index - GURU.Markets
Inspira Technologies' assets include capital and prototypes of its unique non-intubation blood oxygenation system. The book value reflects the financial and engineering basis for creating a new tangible medical device that could transform approaches to treating respiratory failure.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Inspira Technologies Oxy
Inspira Technologies is developing a new technology for blood oxygenation without intubation. It's a MedTech company whose value comes from patents. Its book value is low. Its market capitalization is a bet on its technology's potential to change the standard of respiratory failure treatment. The MvsBCap chart will reflect clinical trial news.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
Inspira Technologies is developing a medical device for blood oxygenation without intubation. Its value lies in its breakthrough technology. The chart shows how investors assess its potential to change the standard of respiratory failure treatment.
Market to book capitalization ratio for the market as a whole
Inspira Technologies is developing a system for oxygenating blood without intubation. This is a potentially revolutionary medical technology. The company's market valuation reflects investors' belief in its ability to change the standard of respiratory failure treatment, not the cost of its laboratory equipment.
Debts of the company, segment and market as a whole
IINN - Company debts Inspira Technologies Oxy
Inspira Technologies, developing an innovative blood oxygenation system, is using capital to complete development, conduct trials, and obtain regulatory approval. Creating a breakthrough medical device is an extremely capital-intensive process. This chart shows how the company is funding its path to potentially changing the standard of patient care.
Market segment debts - Therapeutic medical equipment
Inspira Technologies is developing a medical device for blood oxygenation without the need for intubation. Creating such innovative equipment is a lengthy and expensive process. This chart shows how the company is funding its R&D and clinical trials in its quest to bring a new, less invasive technology to market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Inspira Technologies Oxy
Inspira Technologies develops medical respiratory support equipment. This chart shows the company's reliance on debt to fund its research and market entry. The company's high debt reflects its bet that its technology will prove a viable alternative to traditional ventilators, particularly in emergency situations.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
Inspira Technologies is developing a medical device for blood oxygenation without the need for intubation. The chart shows the overall debt burden in the sector. It helps assess how the company is financing its innovative and potentially disruptive technology, aiming to change the standards of emergency medical care.
Debt to book value of all companies in the market
Inspira Technologies OXY B.H.N. Ltd. develops innovative blood oxygenation systems. For a company bringing new medical equipment to market, the overall financial climate, reflected in this chart, is of great importance. It impacts hospital budgets and their ability to invest in advanced technologies, as well as the company's own capital availability.
P/E of the company, segment and market as a whole
P/E - Inspira Technologies Oxy
For Inspira Technologies, which is developing a technology to oxygenate blood without intubation, this chart reflects hopes for a medical breakthrough. High values indicate investors' belief that their device could become a less invasive alternative to ventilators, opening up a huge market.
P/E of the market segment - Therapeutic medical equipment
This chart shows the average P/E ratio for the medical device sector, where Inspira Technologies is an innovator. The industry's high valuation reflects faith in new technologies. This metric is a benchmark that helps understand how the market views the potential of Inspira's breakthrough technology.
P/E of the market as a whole
Inspira Technologies is developing a system for oxygenating blood without the use of mechanical ventilation. This is a potentially breakthrough technology for treating respiratory failure. This chart shows the sentiment in the medtech sector. It helps understand whether the market believes Inspira's technology can change the standard of care and how likely it is to gain approval and achieve commercial success.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Inspira Technologies Oxy
Inspira Technologies is developing a blood oxygenation system that could become an alternative to traditional invasive mechanical ventilation (MV). This graph demonstrates analysts' confidence that this innovative medical technology will be approved and adopted in intensive care units worldwide.
%20P%2FE%20Inspira%20Technologies%20Oxy&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Inspira-Technologies-Oxy&v=1772639195290 "Chart of the company's future (projected) P/E Inspira Technologies Oxy")
Future (projected) P/E of the market segment - Therapeutic medical equipment
Inspira Technologies is developing a medical device designed to enrich blood with oxygen without the need for invasive mechanical ventilation. This chart shows how its future revenue expectations compare to the industry average. Does the market believe it has the potential to change the standard of respiratory support?
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Therapeutic-medical-equipment&v=1772639195367 "Future (projected) P/E graph of the market segment - Therapeutic medical equipment")
Future (projected) P/E of the market as a whole
Inspira Technologies develops innovative blood oxygenation systems. This is a breakthrough medical technology that requires investment and regulatory approval. This chart, reflecting investor risk appetite, demonstrates the market's willingness to support such projects. Market optimism is making it easier for Inspira to raise capital for development and commercialization.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772639195459 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Inspira Technologies Oxy
Inspira Technologies O.XY. is developing a system for blood oxygenation without the need for intubation. The company's profitability is a future goal, dependent on regulatory approval. This chart shows the investment in developing a medical device that could become an alternative to traditional ventilators and save lives.
Profit of companies in the market segment - Therapeutic medical equipment
Inspira Technologies is developing the ART blood oxygenation system, which aims to be a less invasive alternative to ECMO machines. This could change the way patients with respiratory failure are treated. This chart shows the overall profitability of the medical device sector, where breakthrough technologies capable of improving treatment outcomes have enormous potential.
Overall market profit
Inspira Technologies is developing a medical device for blood oxygenation without intubation. This is a potentially breakthrough technology. However, its path to market requires significant investment. This graph, reflecting the state of financial markets, affects the availability of capital for companies in the development stage.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Inspira Technologies Oxy
Inspira Technologies is developing a medical device that directly oxygenates blood without using the lungs. This could become an alternative to traditional ventilators. This chart summarizes analyst forecasts, which are bets on the success of this breakthrough medical technology and its future commercialization.
%20profit%20of%20the%20company%20Inspira%20Technologies%20Oxy&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Inspira-Technologies-Oxy&v=1772639195664 "Graph of future (projected) profit of the company Inspira Technologies Oxy")
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
Inspira Technologies is developing the ART blood oxygenation system, which aims to be a less invasive alternative to traditional ventilators. The device can increase blood oxygen levels without intubation. This chart shows profitability forecasts for the medical equipment sector, reflecting the need for new technologies in critical care.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Therapeutic-medical-equipment&v=1772639195693 "Graph of future (predicted) profits of companies in a market segment - Therapeutic medical equipment")
Future (predicted) profit of the market as a whole
Inspira Technologies OXY is developing a medical device for blood oxygenation without the need for intubation. The implementation of this new medical technology depends on hospital budgets and its proven effectiveness. This schedule, reflecting the overall economic situation, indirectly affects the healthcare system's financial capacity to purchase innovative equipment.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772639195723 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Inspira Technologies Oxy
Inspira Technologies develops a medical device for respiratory support. This chart shows the market valuation of its innovation. The high price and minimal sales reflect hopes that its technology will become a significant alternative to traditional ventilators.
P/S market segment - Therapeutic medical equipment
Inspira Technologies OXY B.H.N. Ltd. is developing a system for blood oxygenation without the need for intubation. This chart shows the average revenue estimate in the medical device sector. It allows us to estimate the premium investors are placing on the potential of Inspira's technology to revolutionize the treatment of patients with respiratory failure.
P/S of the market as a whole
Inspira Technologies is developing the ART blood oxygenation system, which could become a less invasive alternative to traditional ECMO machines. Their technology is aimed at intensive care units. This chart, showing the valuation of companies with real revenue, highlights the high hopes investors have for breakthrough medical devices.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Inspira Technologies Oxy
Inspira Technologies is developing a blood oxygenation system that could become a less invasive alternative to traditional ventilators. This chart reflects market expectations for this medical innovation. This estimate is based on future sales of its device if it receives regulatory approval and is adopted by hospitals.
%20P%2FS%20Inspira%20Technologies%20Oxy&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Inspira-Technologies-Oxy&v=1772639195879 "The graph of the company's future (projected) P/S Inspira Technologies Oxy")
Future (projected) P/S of the market segment - Therapeutic medical equipment
Inspira Technologies is developing a blood oxygenation system that could become a less invasive alternative to traditional ventilators. This chart shows how the market is pricing its potentially disruptive medical technology.
%20P%2FS%20market%20segment%20graph%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Therapeutic-medical-equipment&v=1772639195933 "Future (projected) P/S market segment graph - Therapeutic medical equipment")
Future (projected) P/S of the market as a whole
Inspira Technologies is developing a medical device for blood oxygenation without the need for intubation. This schedule, reflecting the healthcare system's willingness to invest in innovative technologies, is important to Inspira. Economic growth allows hospitals to purchase new equipment that can improve patient outcomes and reduce the risk of complications.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772639195969 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Inspira Technologies Oxy
Inspira Technologies is developing the ART blood oxygenation system, which aims to be a less invasive alternative to ECMO machines. This chart reflects funding during the development stage, not commercial sales. It illustrates the investment in creating a breakthrough medical device for treating patients with respiratory failure.
Sales of companies in the market segment - Therapeutic medical equipment
Inspira Technologies OXY B.H.N. Ltd. is developing an innovative blood oxygenation technology that could become an alternative to traditional mechanical ventilation. While in the development stage, its business can be roughly divided by potential products. This chart may reflect revenue from grants or partnerships related to one of its technology areas.
Overall market sales
Inspira Technologies Oxy is developing a medical device that can enrich blood with oxygen without the need for intubation. This is a potentially breakthrough technology for treating patients with respiratory failure. The company's success depends on clinical trials and regulatory approval, and it could change the standards of care in intensive care.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Inspira Technologies Oxy
Inspira Technologies is developing an ART blood oxygenation system, which it believes could become a less invasive alternative to traditional ECMO. Future sales projections are based on expectations of regulatory approval and the adoption of this potentially revolutionary technology in intensive care units.
%20sales%20of%20the%20company%20Inspira%20Technologies%20Oxy&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Inspira-Technologies-Oxy&v=1772639196052 "Schedule of future (projected) sales of the company Inspira Technologies Oxy")
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
Inspira Technologies is developing a system for oxygenating blood without the need for invasive mechanical ventilation. This chart shows expectations for the therapeutic medical equipment sector. It helps assess analysts' forecasts for demand for new, less invasive respiratory support technologies.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Therapeutic-medical-equipment&v=1772639196073 "Schedule of future (projected) sales of companies in the market segment - Therapeutic medical equipment")
Future (projected) sales of the market as a whole
Inspira Technologies is developing an innovative blood oxygenation system. Demand for its future device will depend on hospital budgets. This chart of overall sales forecasts reflects the economic climate that allows medical institutions to invest in expensive equipment.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772639196077 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Inspira Technologies Oxy
Inspira Technologies OXY B.H.N. Ltd. is developing an innovative blood oxygenation system that could become an alternative to invasive mechanical ventilation. This chart shows the company's financial trajectory during the R&D phase, where significant investments in the creation of a breakthrough medical device are the foundation for future profitability.
Market segment marginality - Therapeutic medical equipment
Inspira Technologies is developing a medical device for blood oxygenation without the need for intubation. The company's profitability during the development phase depends on its ability to cost-effectively conduct research and move toward commercialization. The chart shows their operating costs as they move toward bringing this potentially breakthrough technology to market.
Market marginality as a whole
Inspira Technologies Oxy is developing a medical device designed to directly enrich blood with oxygen, without using the lungs. This could become an alternative to traditional ventilators. This chart shows the profitability of mature medtech companies, but for IINN, a breakthrough technology capable of transforming intensive care is the key to creating enormous value.
Employees in the company, segment and market as a whole
Number of employees in the company Inspira Technologies Oxy
Inspira Technologies is developing a system for blood oxygenation without intubation. This graph shows the team of engineers and medical professionals. The growth of this team is a key indicator of progress toward regulatory approval for their potentially revolutionary medical device.
Share of the company's employees Inspira Technologies Oxy within the market segment - Therapeutic medical equipment
Inspira Technologies is developing a medical device that enriches blood with oxygen without the need for invasive ventilation. Commercializing such a breakthrough product requires a large team. This figure reflects the company's investment in creating new life-saving technology.
Number of employees in the market segment - Therapeutic medical equipment
Inspira Technologies is developing a system for blood oxygenation without the need for intubation. This chart shows employment in the therapeutic medical equipment sector. The growing number of engineers and clinicians in the field of respiratory support reflects the search for less invasive and safer methods for patients with respiratory failure.
Number of employees in the market as a whole
Inspira Technologies develops blood oxygenation systems. Demand for such equipment can spike during respiratory epidemics, but is generally driven by hospital needs. This makes it less dependent on general economic cycles, as reflected in this chart.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Inspira Technologies Oxy (IINN)
Inspira Technologies OXY B.H.N. Ltd. is developing a medical device for blood oxygenation without intubation. Medtech startups often have high market capitalization per employee. This chart shows that investors highly value the potential of this breakthrough technology, which could change the standards of care in intensive care.
%20of%20the%20company%20Inspira%20Technologies%20Oxy%20(IINN)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Inspira-Technologies-Oxy-IINN&v=1772639196310 "Chart of market capitalization per employee (in thousands of dollars) of the company Inspira Technologies Oxy (IINN)")
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Inspira Technologies OXY B.H.N. Ltd. is developing an innovative blood oxygenation system that could become an alternative to traditional mechanical ventilation. In the medical device sector, this indicator reflects the market's appreciation of their breakthrough technology. It is a measure of investor confidence in the company's ability to transform the standards of intensive care.
%20by%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Therapeutic-medical-equipment&v=1772639196314 "Market capitalization per employee (in thousands of dollars) by market segment - Therapeutic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
Inspira Technologies Oxy has developed a technology for direct blood oxygenation, without the need for intubation. This is a potentially breakthrough medical technology for resuscitation. The graph reflects the enormous market expectations for this innovation.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772639196326 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Inspira Technologies Oxy (IINN)
Inspira Technologies (IINN) is developing an innovative blood oxygenation system (ART) designed to enrich blood with oxygen without invasive ventilation. It is an R&D company in the pre-commercial stage. This negative graph shows how much capital is "burned" per engineer and physician to create and validate this potentially revolutionary medical device.
%20Chart%20Inspira%20Technologies%20Oxy%20(IINN)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Inspira-Technologies-Oxy-IINN&v=1772639196329 "Company Profit Per Employee (in thousands of dollars) Chart Inspira Technologies Oxy (IINN)")
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Inspira Technologies is developing a blood oxygenation system that could potentially replace invasive mechanical ventilation. In the disruptive medical technology sector, value is created by a team of engineers and clinicians. This metric reflects how financially productive their R&D efforts are compared to other medtech startups.
%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Therapeutic-medical-equipment&v=1772639196343 "Chart of profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Inspira Technologies (IINN) develops innovative blood oxygenation systems (an alternative to ECMO). It is a MedTech company in the R&D stage. Negative profit per employee is the norm. The chart shows the "cost" of the team of engineers and doctors trying to commercialize this complex technology.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772639196368 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Inspira Technologies Oxy (IINN)
Inspira Technologies is developing a medical device for blood oxygenation without intubation. While the company is still in the approval stage, it has not yet generated commercial revenue. This timeline will determine whether its innovative technology will find a place in intensive care units.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Inspira-Technologies-Oxy-IINN&v=1772639196393 "Sales chart per company employee Inspira Technologies Oxy (IINN)")
Sales per employee in the market segment - Therapeutic medical equipment
Inspira Technologies is developing an ART system designed to oxygenate blood without invasive ventilation. This is a breakthrough technology. This chart compares revenue per employee (R&D) with the industry average. It reflects how productive their development is on its way to market.
Sales per employee for the market as a whole
Inspira Technologies (IINN) is an Israeli medtech company developing an innovative intubation-free blood oxygenation (IVX) system (a competitor to ECMO). This is an R&D company in the pre-commercialization stage. The company has no revenue. This graph will reflect $0, as all employees (engineers) are focused on development.
Short shares by company, segment and market as a whole
Shares shorted by company Inspira Technologies Oxy (IINN)
Inspira Technologies (IINN) is developing a new technology for blood oxygenation (oxygenation) without using the lungs. It's potentially revolutionary, but still in the very early stages. This chart shows the number of investors who consider this technology too complex and far from clinical reality.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Inspira-Technologies-Oxy-IINN&v=1772639196477 "Short Shares Chart for the Company Inspira Technologies Oxy (IINN)")
Shares shorted by market segment - Therapeutic medical equipment
Inspira Technologies (IINN) is developing a breakthrough medical system that oxygenates blood without invasive ventilation. This is an early-stage medical device sector. This chart illustrates the general market skepticism surrounding this niche. Investors are shorting the segment, doubting the success of clinical trials or the speed of regulatory approval.
Shares shorted by the overall market
Inspira Technologies is developing a new blood oxygenation technology (an alternative to ECMO). This is an R&D project. This chart illustrates the overall market pessimism. Investors are panicking and unwilling to fund the development of complex medical equipment. They see a "cash burn" and fear the product won't reach the market.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Inspira Technologies Oxy (IINN)
Inspira Technologies is developing a blood oxygenation system (ART), which aims to be a less invasive alternative to ECMO. This breakthrough technology is not yet approved. This oscillator measures hype, showing overbought peaks (above 70) at announcements and deep oversold troughs (below 30) pending FDA approval.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Inspira-Technologies-Oxy-IINN&v=1772639196527 "RSI 14 indicator chart for the company's stock Inspira Technologies Oxy (IINN)")
RSI 14 Market Segment - Therapeutic medical equipment
Inspira Technologies is developing an innovative system (ART) for direct blood oxygenation (oxygen saturation), without using the lungs. It is a potential alternative to mechanical ventilation. This graph tracks the collective momentum in the therapeutic medical device sector. It helps us understand whether the IINN trend is unique or a sign of general "overheating" in the medtech sector.
RSI 14 for the overall market
Inspira (IINN), a medical equipment developer, sees both hospital budgets and risk appetite in this chart. In a euphoric mood, investors are ready to finance the "future of medicine," and hospitals are ready to buy expensive innovations. In a panic, investors flee unprofitable R&D projects, and hospitals freeze capital expenditures.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast IINN (Inspira Technologies Oxy)
Inspira Technologies (IINN) is an Israeli company developing ART technology: a system for oxygenating blood without invasive ventilation. This chart shows the speculative average price target from analysts, which is almost entirely dependent on their belief in this breakthrough technology and its clinical success.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-IINN-Inspira-Technologies-Oxy&v=1772639196796 "A chart showing analyst consensus forecasts for the expected stock price. IINN (Inspira Technologies Oxy)")
The difference between the consensus estimate and the actual stock price IINN (Inspira Technologies Oxy)
Inspira Technologies is a medical technology company developing ART, a breakthrough system for blood oxygenation without the need for intubation (ventilator ventilation). This chart shows the upside and downside potential analysts see in the stock. It measures the gap between the price and forecast, reflecting their belief in this potentially revolutionary technology for intensive care.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-IINN-Inspira-Technologies-Oxy&v=1772639196815 "A chart showing the difference between the consensus forecast and the actual stock price. IINN (Inspira Technologies Oxy)")
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
Inspira Technologies (IINN) is an Israeli company developing ART technology—a system for oxygenating blood without intubation for patients with respiratory failure. This chart shows general expectations for the therapeutic medical equipment sector. It reflects whether experts believe in this R&D breakthrough.
Analysts' consensus forecast for the overall market share price
Inspira Technologies (IINN) is an Israeli medical technology company that aims to replace ventilators. They are developing a device that directly oxygenates blood, without invading the lungs. This chart shows the overall risk appetite. It reflects the market's willingness to fund breakthrough, yet unapproved, medical technologies.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Inspira Technologies Oxy
Inspira Technologies is a MedTech R&D company working to revolutionize critical care. They are developing a noninvasive blood oxygenation (ART) system designed to replace traditional, invasive ventilators (intubation). This graph is a clear indicator of their R&D. It reflects the market's faith in their futuristic technology and their (very long and risky) path to FDA approval.
AKIMA Market Segment Index - Therapeutic medical equipment
Inspira Technologies (IINN) is developing an innovative ART system. It is a less invasive alternative to ECMO, designed for patients with respiratory failure. The chart shows the average index for the segment, helping investors assess how this potentially disruptive medical technology compares to the average in the medical device sector.
The AKIM Index for the overall market
Inspira Technologies is an Israeli company developing blood oxygenation systems (artificial lungs) for early intervention. This chart, reflecting the market average, is a backdrop. It helps assess how Inspira Technologies, which aims to change the standards of intensive care, compares to overall macroeconomic trends.
